Regulatory News

Issue of Shares and Total Voting Rights

RNS Number : 0438U
Darktrace PLC
30 November 2021

30 November 2021

Darktrace plc


Issue and allotment of Shares under the Award Incentive Plan and Total Voting Rights

Darktrace announces the exercise of options granted under its Darktrace plc 2021 Award Incentive Plan to a member of the advisory council. The Company has therefore issued and allotted an aggregate of 200,000 new ordinary shares of 1 pence each in the Company (the "New Shares"). An application has been made for the New Shares to be admitted to the Premium Listing Segment of the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange.

The New Shares will rank pari passu in all respects with Darktrace's existing ordinary shares of 1 penny each ("Ordinary Shares"). It is expected that admission will become effective on 3 December, 2021.

As a result of the 200,000 ordinary shares issued, the total number of ordinary shares outstanding is 699,211,705. Each Ordinary Share carries the right to one vote. Darktrace does not hold any shares in treasury. Therefore, the total voting rights figure of 699,211,705 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Darktrace under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.



Luk Janssens - Head of Investor Relations   [email protected]




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.